To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Please provide your email address to receive an email when new articles are posted on . A novel AI multimodal model outperformed Oncotype DX in overall distant recurrence rate at 15 years. Additional ...

At the San Antonio Breast Cancer Symposium, researchers presented findings on Clarity BCR, a multimodal multitask deep-learning algorithm that aims to estimate late distant recurrence risk in hormone ...

Greenwich LifeSciences Inc. (NASDAQ: GLSI) stock is trading higher on Monday, with a session volume of 2.804 million compared to the average volume of 81.85 thousand, as per data from Benzinga Pro.

SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR ...

Objective: This study aimed to develop a machine learning–based model to predict recurrence risk after perianal abscess surgery, thereby supporting personalized follow-up and intervention strategies.

At a median follow-up of 106 months, cumulative incidence of metastasis was 4.8% in the chRCC cohort, compared to 0% in the oncocytoma and ORNLMP cohorts. Oncocytomas and oncocytic neoplasms of low ...

Development and Validation of Emoji Response Scales for Assessing Patient-Reported Outcomes The Artera multimodal AI (MMAI) platform, using digital histopathology and clinical data, was applied to ...

The U.S. Department of Energy building is seen behind a sign marking the location of the agency's headquarters on March 18, 2025, in Washington, D.C. (Photo by J.David Ake/Getty Images) The Department ...

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality.

Oct 1 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab, Takeda Pharmaceuticals (4502.T), opens new tab and Astex Pharmaceuticals are coming together to share proprietary data for training an ...

Anthropic is starting to train its models on new Claude chats. If you’re using the bot and don’t want your chats used as training data, here’s how to opt out. Anthropic is prepared to repurpose ...